Ea. Forsyth et al., TRANSFORMING GROWTH-FACTOR-BETA-1 INHIBITS THE PROLIFERATIVE EFFECT OF INSULIN ON HUMAN INFRAGENICULAR VASCULAR SMOOTH-MUSCLE CELLS, Journal of vascular surgery, 25(3), 1997, pp. 432-436
Purpose: The distribution of atherosclerotic arterial disease in diabe
tes mellitus characteristically involves the infragenicular arterial t
ree including the anterior tibial, posterior tibial, and peroneal arte
ries. The proliferation of vascular smooth muscle cell (VSMC) is essen
tial in the development of the atherosclerotic lesion. It has long bee
n held that insulin plays a causative role in the formation of the ath
erosclerotic lesion in diabetes. We studied the role played by insulin
in the proliferation of these cells in culture and the interaction of
insulin with transforming growth factor beta 1 (TGF beta 1), a factor
known. for its possible inhibitory effects. Methods: We have grown an
d characterized a line of VSMC harvested from atherosclerotic infragen
icular arteries of human subjects undergoing below-knee amputation. Th
e cultures were defined as being of VSMC origin by immunohistochemical
staining with or-smooth muscle actin. Confluent cultures of passages
4 through 7 were seeded into six well plates at a density of 5000 cell
s/well. After serum deprivation the cells were exposed to insulin (100
ng/ml) alone or in combination with TGF beta 1 (6 ng/ml). Results: Ou
r findings indicate that a 48-hour incubation with insulin augments th
e proliferation of human infragenicular VSMC, producing a 207% increas
e in cell number when compared with control cells (11,328 +/- 686, n =
56 vs 3682 +/- 182, n = 87; p < 0.0001). The addition of TGF beta 1 i
n combination with insulin abolished the accelerated growth rate seen
in test groups treated with insulin alone (3614 +/- 247, n = 32 vs 11,
328 +/- 686, n = 56; p < 0.0001). Conclusion: These results strongly s
uggest that insulin is a potent stimulant of human infragenicular VSMC
proliferation. The mitogenic effect of insulin is inhibited by TGF be
ta 1, producing proliferation rates comparable to those observed in co
ntrol cells incubated with serum-free media.